Leveraging valine-restriction-induced DNA damage for targeted cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• The tumor microenvironment significantly influences cancer progression and treatment efficacy.
• Metabolic alterations in cancer cells create unique vulnerabilities.
• Histone deacetylases (HDACs) play crucial roles in gene regulation and DNA repair.

Purpose of the Study:

• To investigate the impact of specific amino acid deprivation on cancer cell behavior.
• To explore the role of HDAC6 in response to metabolic stress.
• To identify potential therapeutic targets based on metabolic vulnerabilities.

Main Methods:

• Utilized cell culture models with controlled amino acid availability (valine deprivation).
• Employed techniques such as Western blotting and immunofluorescence to track HDAC6 localization.
• Assessed DNA damage using assays like the comet assay and by measuring markers of DNA repair.

Main Results:

• Valine deprivation induced the translocation of HDAC6 from the cytoplasm to the nucleus in cancer cells.
• Nuclear accumulation of HDAC6 correlated with increased levels of DNA damage.
• Inhibition of HDAC6 activity modulated the DNA damage response.

Conclusions:

• Metabolic stress, specifically valine deprivation, can alter the epigenetic landscape by affecting HDAC6 nuclear entry.
• The observed DNA damage accumulation presents a potential therapeutic window for exploiting metabolic vulnerabilities in cancer.
• Targeting HDAC6 in combination with strategies that induce metabolic stress may enhance cancer treatment outcomes.